Header cover image

French (CAC) Healthcare Sector Analysis

UpdatedJan 24, 2022
DataAggregated Company Financials
Companies84
  • 7D-0.4%
  • 3M-4.6%
  • 1Y6.4%
  • YTD-7.0%

Over the last 7 days, the Healthcare industry has remained flat, although notably Eurofins Scientific declined by 3.2%. As for the the longer term, the industry is up 6.4% over the past 12 months.

Sector Valuation and Performance

Has the French Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Mon, 24 Jan 2022€211.2b€71.8b€8.5b20.8x
Wed, 22 Dec 2021€222.0b€71.7b€8.5b23.7x
Fri, 19 Nov 2021€226.3b€71.8b€8.5b23.7x
Sun, 17 Oct 2021€216.3b€70.5b€8.1b21.5x
Tue, 14 Sep 2021€225.4b€70.2b€8.1b25.9x
Thu, 12 Aug 2021€223.8b€70.2b€8.1b27.9x
Mon, 07 Jun 2021€204.0b€68.5b€14.2b28x
Sun, 28 Feb 2021€187.8b€67.9b€14.0b29x
Wed, 02 Dec 2020€193.5b€67.2b€12.3b30.4x
Sat, 05 Sep 2020€191.2b€66.3b€11.7b35x
Tue, 09 Jun 2020€186.6b€66.6b€4.0b28.3x
Mon, 02 Mar 2020€167.7b€65.7b€3.3b34.8x
Thu, 05 Dec 2019€168.6b€64.1b€3.8b36.2x
Sun, 08 Sep 2019€157.3b€63.1b€4.4b28.9x
Sat, 01 Jun 2019€148.5b€61.6b€5.3b29.4x
Tue, 05 Mar 2019€146.9b€60.0b€5.2b26.3x
PE Ratio

24.5x

Total Market Cap: €144.8bTotal Earnings: €5.2bTotal Revenue: €60.0b0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 20.8x which is lower than its 3-year average PE of 29.9x. It appears they believe that earnings will not grow as fast as they have historically.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 18% per year over the last three years, and revenues for these companies have grown 6.2% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the French Healthcare sector?

Life Sciences0.66%
Pharma0.082%
Healthtech-2.11%
Medical Equipment-2.17%
Healthcare Services-4.41%
Biotech-5.63%

Industry PE: Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 34.7x. This is likely because analysts are expecting annual earnings growth of 19%, which is higher than its past year's earnings growth of 16% per year. Meanwhile, investors are most pessimistic about the Biotech industry, which is trading below its 3-year average of 19.3x.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 55% over the next 5 years. However this is lower than its past earnings growth rate of 158% per year. Meanwhile, the Medical Equipment industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DIM Sartorius Stedim Biotech€377.002.7%
+€921.8m
14.3%PE66.4x
SAN Sanofi€90.940.4%
+€401.7m
11.6%PE18.5x
BOI Boiron€39.008.9%
+€56.1m
9.9%PE38.7x
ALVMG Visiomed Group€0.1918.8%
+€16.4m
-78.5%PS48.6x
TNG Transgene€2.603.4%
+€8.3m
7.0%PS28.2x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BOI

€39.00

Boiron

7D

8.9%

1Y

9.9%

VIRP

€360.00

Virbac

7D

-6.6%

1Y

63.6%

VLA

€15.66

Valneva

7D

-4.3%

1Y

72.5%

SAN

€90.94

Sanofi

7D

0.4%

1Y

11.6%

IVA

€11.26

Inventiva

7D

1.4%

1Y

-24.4%